The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseKetogenic diet in neuromuscular and neurodegenerative diseasesPutative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's DiseaseParkinson's Disease: The Mitochondria-Iron LinkNeuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathwaysSulfated Hetero-Polysaccharides Protect SH-SY5Y Cells from H₂O₂-Induced Apoptosis by Affecting the PI3K/Akt Signaling PathwayNicotine from cigarette smoking and diet and Parkinson disease: a review.Environmental enrichment alters protein expression as well as the proteomic response to cocaine in rat nucleus accumbens.Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicityZinc: indications in brain disorders.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.Transcriptome profiling of expression changes during neuronal death by RNA-SeqGanoderma Lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress.Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson's disease.New insights on the mitochondrial proteome plasticity in Parkinson's disease.Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis.Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.Parkin and PINK1 functions in oxidative stress and neurodegeneration.Acute exposure to a Mn/Zn ethylene-bis-dithiocarbamate fungicide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans.L-3-n-Butylphthalide Protects HSPB8 K141N Mutation-Induced Oxidative Stress by Modulating the Mitochondrial Apoptotic and Nrf2 Pathways.The efficacy of the ketogenic diet on motor functions in Parkinson's disease: A rat modelMethyl Yellow: A Potential Drug Scaffold for Parkinson's Disease.Isorhynchophylline Attenuates MPP+-Induced Apoptosis Through Endoplasmic Reticulum Stress- and Mitochondria-Dependent Pathways in PC12 Cells: Involvement of Antioxidant Activity.Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes.Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.1 H qNMR Quantification of Annonaceous Acetogenins in Crude Extracts of Annona muricata L. Fruit Pulp.Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.
P2860
Q21131066-4B901B44-1D73-486C-83DD-F23266B30EDBQ21284703-44519573-BA44-4CA4-AAAF-FEE9AB0FC06BQ26738450-64209660-8D40-416A-9064-A35F1BA616D4Q26746899-CE5FB647-BF73-43AA-84A7-D4F2738E240BQ26779424-D8862373-95FE-40A8-A15B-F24798E43D89Q33612237-8EA9D970-A81A-4D4C-8C79-BB74B1C27E16Q33862534-A29A54DE-DB9B-471F-9678-EE7E2CEBBE8EQ33925432-7E8500D6-D7EC-4705-919B-0F7AE97A3CDCQ34003885-8294CF3B-D3F1-4612-B4CD-87E3E6345DBFQ34461683-1D0AF069-6361-4E71-BDE9-1360BCD55DD2Q35412397-6CD18EF9-934F-486D-AD31-6033F4531732Q35507433-2F28D939-40F3-4E6A-A9B8-A7DA6FF98E00Q36260495-AFC5B416-8523-4B57-B8F2-228AD9B1009EQ36267794-5EF9E58A-CF4C-4B9C-B7D1-1B3429085E85Q37019188-B10FA067-1013-45C2-9F77-AA720BC59D33Q37325666-5DFA8E6F-85D3-4782-A991-B59D1CA2408FQ37436444-AD2D9E96-F5C1-41F1-BE22-CBE18A1EF440Q38452561-94B5632E-3DBB-4B93-A68A-D006C9F7CC30Q38790406-7D5265BD-208B-4D7B-A593-A2460DA7FE26Q38928728-52AF43EC-5B81-4A8A-9D24-238977743E2EQ39054548-0DEB974E-55DF-438E-9536-570DEDBDC57AQ39355888-22AEB344-9C48-4650-9266-67D83E2BD7CEQ40988486-2A6B5D1C-5164-4A82-B2AF-D31CDA537E1BQ41853478-946C5592-0F2E-4773-8BFA-91080BEE7B12Q45151001-B2A1EEF6-1524-4F08-AC82-B3680F3FD27AQ46319028-CFF030A2-A12A-46F9-A298-47F5F3C795DBQ47117694-958CBA46-C2C6-4194-9C61-0A751EB4A857Q48335945-9E0931A9-92E2-4D90-86C5-61F2CAC1B4ACQ50919414-1FFB9060-A005-40B6-8613-3DB9772EECE5Q52752399-87696631-88C9-4AC8-80FE-FEA2391FE0B7Q55686847-12E8D252-2E9F-4C94-A867-F48A5204C84A
P2860
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
@en
type
label
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
@en
prefLabel
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
@en
P2860
P921
P356
P1476
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
@en
P2093
Angelique Camilleri
Neville Vassallo
P2860
P304
P356
10.1111/CNS.12264
P577
2014-04-07T00:00:00Z